Septerna, Inc.
SEC CIK 1984086 · SEPN · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2024 - 2026 |
| RA Capital Management, LLC | Director | filed 2024 - 2026 |
| Sharp Shalini | Director | filed 2024 - 2026 |
| Kolchinsky Peter | Director | filed 2024 - 2026 |
| Tong Jeffrey K | Director | filed 2024 - 2026 |
| Gottesdiener Keith Michael | Director | filed 2025 - 2026 |
| Shah Rajeev M. | Director | filed 2024 - 2026 |
| Ezekowitz Alan | Director | filed 2024 - 2026 |
| Coulie Bernard | Director | filed 2024 - 2026 |
| Simson Jake | Director | filed 2024 - 2026 |
| Bassan Abraham | Director | filed 2024 - 2026 |
| RA Capital Nexus Fund III, L.P. | Director | filed 2024 - 2026 |
| Finer Jeffrey | Director · Chief Executive Officer | filed 2024 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shaikhly Samira | Chief People Officer | filed 2024 - 2026 |
| Long Daniel D. | SVP, Drug Discovery | filed 2024 - 2026 |
| Bhatt Elizabeth | President and COO | filed 2024 - 2026 |
| Labrucherie Gil M | Chief Financial Officer | filed 2025 - 2026 |
| Wilson Mark Andrew | Chief Legal Officer | filed 2026 - 2026 |
| Kim Jae B. | Chief Medical Officer | filed 2024 - 2026 |
| Klein Uwe | SVP, Biological Sciences | filed 2024 - 2026 |
| Xiao Ran | Interim CFO | filed 2024 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.